Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pulmonology
•
Pulmonary Infections
Would you treat a sputum culture positive for Aspergillus niger despite an atypical CT chest and a negative serum galactomannan in an immunosuppressed patient who is too high risk for bronchoscopy?
Related Questions
Do you favor timely bronchoscopy for diagnostics over close surveillance in mildly symptomatic patients with CT findings suspicious for NTM infection who are not able to expectorate?
Do you use steroids in the management of PJP pneumonia with severe hypoxia in HIV negative patients?
Are there clinical scenarios in which you would start empiric treatment for pulmonary TB without microbiologic confirmation?
Is there a role for chronic suppressive oral or inhaled therapy for recurrent Burkholderia cepacia pneumonia causing frequent hospitalizations in a patient with severe bronchiectasis with or without underlying cystic fibrosis?
Does your approach to treating latent tuberculosis differ in a patient on anti-fibrotic therapy?
Do you continue previously prescribed antiretroviral therapy alongside steroid therapy in a patient with established HIV infection who is later diagnosed with TB meningitis?
Is there a role for repeat surveillance blood cultures in patients with prosthetic valve endocarditis without associated cardiac abscess after a 6 week course of antibiotic treatment without surgical intervention?
When do you consider the use of corticosteroids in patients diagnosed with EVALI?
How do you approach the use of chronic azithromycin in patients with CF who may require therapy with IV tobramycin in the future?
Did the low rate of COPD exacerbations in the BOREAS cohort overall confound the results of the study?